Kristine F. Moseholm

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Long-term dementia risk in metabolic dysfunction-associated steatotic liver disease: a population-based study.

Long-term dementia risk in metabolic dysfunction-associated steatotic liver disease: a population-based study.

Journal: Metabolic brain disease

Published: August 29, 2025

The potential of circulating nonesterified fatty acids and sphingolipids in the biological understanding of cognitive decline and dementia.

The potential of circulating nonesterified fatty acids and sphingolipids in the biological understanding of cognitive decline and dementia.

Journal: Current opinion in lipidology

Published: December 06, 2024

Circulating non-esterified fatty acids, risk of dementia and cognitive decline: The cardiovascular health study and multi-ethnic study of atherosclerosis.

Circulating non-esterified fatty acids, risk of dementia and cognitive decline: The cardiovascular health study and multi-ethnic study of atherosclerosis.

Journal: Neurobiology of aging

Published: June 28, 2024

Circulating Ketone Bodies, Pyruvate, and Citrate and Risk of Cognitive Decline, Structural Brain Abnormalities, and Dementia.

Circulating Ketone Bodies, Pyruvate, and Citrate and Risk of Cognitive Decline, Structural Brain Abnormalities, and Dementia.

Journal: Aging and disease

Published: June 27, 2024

Association of Tumor Necrosis Factor-α Inhibitors with Incident Dementia: Analysis Based on Population-Based Cohort Studies.

Association of Tumor Necrosis Factor-α Inhibitors with Incident Dementia: Analysis Based on Population-Based Cohort Studies.

Journal: Drugs & aging

Published: March 17, 2024

Circulating sphingolipids in relation to cognitive decline and incident dementia: The Cardiovascular Health Study.

Circulating sphingolipids in relation to cognitive decline and incident dementia: The Cardiovascular Health Study.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: February 27, 2024

Circulating sphingolipids and subclinical brain pathology: the cardiovascular health study.

Circulating sphingolipids and subclinical brain pathology: the cardiovascular health study.

Journal: Frontiers in neurology

Published: February 13, 2024

Circulating cell-free DNA and its association with cardiovascular disease: what we know and future perspectives.

Circulating cell-free DNA and its association with cardiovascular disease: what we know and future perspectives.

Journal: Current opinion in lipidology

Published: October 06, 2023

Should young researchers engage with interdisciplinary research?: A reflective proposal from early career researchers at the Center for Healthy Aging.

Should young researchers engage with interdisciplinary research?: A reflective proposal from early career researchers at the Center for Healthy Aging.

Journal: Acta physiologica (Oxford, England)

Published: July 22, 2023

Serum NfL and GFAP are associated with incident dementia and dementia mortality in older adults: The cardiovascular health study.

Serum NfL and GFAP are associated with incident dementia and dementia mortality in older adults: The cardiovascular health study.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 01, 2023

The evolutionarily conserved miRNA-137 targets the neuropeptide hypocretin/orexin and modulates the wake to sleep ratio.

The evolutionarily conserved miRNA-137 targets the neuropeptide hypocretin/orexin and modulates the wake to sleep ratio.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 22, 2022

Sphingomyelins and ceramides: possible biomarkers for dementia?

Sphingomyelins and ceramides: possible biomarkers for dementia?

Journal: Current opinion in lipidology

Published: December 08, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026